46.46.Z - Wholesale of pharmaceutical goods
46.90.Z - Non-specialised wholesale trade
47.19.Z - Other retail sale in non-specialised stores
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
70.22.Z - Business and other management consultancy activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,3 | 7 | -1,5 | -120,9 |
EBITDA | 0,5 | 8 | -0,2 | -102,6 |
Short time liabilities | 1,7 | 2,4 | 1,4 | -43,1 |
Equity capital | 1,6 | 1,5 | 5,7 | 287,3 |
Operating profit (EBIT) | 0,4 | 7,6 | -0,5 | -107,2 |
Assets | 6,6 | 12,7 | 10 | -21,3 |
Net profit (loss) | 0,3 | 5,6 | -1,5 | -126,3 |
Cash | 0,3 | 7,3 | 5,2 | -28,8 |
Net income from sale | 9,7 | 20,5 | 11,8 | -42,5 |
Liabilities and provisions for liabilities | 5 | 5,6 | 4,3 | -22 |
Working assets | 3,1 | 9,9 | 7,5 | -24,6 |
Depreciation | 0,1 | 0,4 | 0,3 | -6,2 |
% | % | % | p.p. | |
Profitability of capital | 18,9 | 381,2 | -25,9 | -407,1 |
Equity capital to total assets | 24,3 | 11,5 | 56,6 | 45,1 |
Gross profit margin | 3,4 | 34,2 | -12,4 | -46,6 |
EBITDA Margin | 4,6 | 38,9 | -1,8 | -40,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 63 | 43 | 43 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane